|
| Ivo Buchhalter | German Cancer Research Centre (DKFZ) |
| Ivo Buchhalter | Cancer Research Centre (DKFZ) |
| Ivo Buchhalter | German Cancer Research Center (DKFZ) |
| Ivo Buchhalter | Institute for Pharmacy and Molecular Biotechnology (IPMB) and BioQuant, Heidelberg University |
| Ivo Buchhalter | German Cancer Research Centre (DKFZ) |
| Ivo Buchhalter | Institute for Pharmacy and Molecular Biotechnology (IPMB) and BioQuant, Heidelberg University |
| Ivo Buchhalter | German Cancer Research Center (DKFZ) |
| Ivo Buchhalter | Cancer Research Centre (DKFZ) |
| Esther Rheinbay | Broad Institute of Harvard and MIT |
| Esther Rheinbay | Massachusetts General Hospital Cancer Center and Department of Pathology |
| Keiran Raine | Wellcome Sanger Institute |
| Kortine Kleinheinz | German Cancer Research Centre (DKFZ) |
| Sergi Beltran | Barcelona Institute of Science and Technology (BIST) |
| Marta Gut | Barcelona Institute of Science and Technology (BIST) |
| Daniel H??bschmann | German Cancer Research Centre (DKFZ) |
| Daniel H??bschmann | |
| Daniel H??bschmann | National Center for Tumor diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ) |
| Daniel H??bschmann | University Hospital Heidelberg |
| Daniel H??bschmann | Institute for Pharmacy and Molecular Biotechnology (IPMB) and BioQuant, Heidelberg University |
| Daniel H??bschmann | German Cancer Research Centre (DKFZ) |
| Daniel H??bschmann | Institute for Pharmacy and Molecular Biotechnology (IPMB) and BioQuant, Heidelberg University |
| Daniel H??bschmann | University Hospital Heidelberg |
| Daniel H??bschmann | National Center for Tumor diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ) |
| Daniel H??bschmann | |
| Barbara Hutter | Cancer Research Centre (DKFZ) |
| Barbara Hutter | National Center for Tumor diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ) |
| Barbara Hutter | Cancer Research Centre (DKFZ) |
| Barbara Hutter | National Center for Tumor diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ) |
| Dimitri Livitz | Broad Institute of Harvard and MIT |
| Marc D Perry | University of California san francisco |
| Mara Rosenberg | Broad Institute of Harvard and MIT |
| Mara Rosenberg | Massachusetts General Hospital Cancer Center and Department of Pathology |
| Mara Rosenberg | Broad Institute of Harvard and MIT |
| Mara Rosenberg | Massachusetts General Hospital Cancer Center and Department of Pathology |
| Gordon Saksena | Broad Institute of Harvard and MIT |
| Gordon Saksena | Broad Institute of Harvard and MIT |
| Roland Eils | Center for Digital Health, Berlin Institute of Health (BIH) and Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin |
| Roland Eils | Heidelberg University Hospital and BioQuant |
| Roland Eils | Center for Digital Health, Berlin Institute of Health (BIH) and Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin |
| Roland Eils | Heidelberg University Hospital and BioQuant |
| Daniela S Gerhard | National Cancer Institute, US National Institutes of Health |
| Daniela S Gerhard | National Cancer Institute, US National Institutes of Health |
| Peter J Campbell | Wellcome Sanger Institute |
| Matthias Schlesner | German Cancer Research Centre (DKFZ) |
| Matthias Schlesner | German Cancer Research Centre (DKFZ) |
| Matthias Schlesner | German Cancer Research Centre (DKFZ) |
| Matthias Schlesner | German Cancer Research Centre (DKFZ) |
| Ivo Gut | Barcelona Institute of Science and Technology (BIST) |
| Ivo Gut | Universitat Pompeu Fabra (UPF) |